Truist Financial’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $149M | Sell |
754,121
-15,219
| -2% | -$2.93M | 0.2% | 98 |
|
|
2025
Q4 | $141M | Buy |
769,340
+268,954
| +54% | +$47.2M | 0.19% | 104 |
|
|
2025
Q3 | $76.8M | Buy |
500,386
+93,509
| +23% | +$14.2M | 0.1% | 174 |
|
|
2025
Q2 | $56.9M | Buy |
406,877
+54,131
| +15% | +$7.59M | 0.08% | 215 |
|
|
2025
Q1 | $51.9M | Buy |
352,746
+230,784
| +189% | +$33.4M | 0.08% | 213 |
|
|
2024
Q4 | $16M | Sell |
121,962
-6,258
| -5% | -$876K | 0.03% | 448 |
|
|
2024
Q3 | $20M | Buy |
128,220
+2,981
| +2% | +$481K | 0.03% | 397 |
|
|
2024
Q2 | $19.5M | Buy |
125,239
+5,537
| +5% | +$833K | 0.03% | 412 |
|
|
2024
Q1 | $16.2M | Sell |
119,702
-2,143
| -2% | -$284K | 0.02% | 483 |
|
|
2023
Q4 | $16.4M | Buy |
121,845
+2,644
| +2% | +$344K | 0.03% | 462 |
|
|
2023
Q3 | $16.1M | Sell |
119,201
-4,434
| -4% | -$606K | 0.03% | 444 |
|
|
2023
Q2 | $17.7M | Buy |
123,635
+3,371
| +3% | +$496K | 0.03% | 424 |
|
|
2023
Q1 | $16.7M | Buy |
120,264
+1,513
| +1% | +$204K | 0.03% | 428 |
|
|
2022
Q4 | $16.1M | Sell |
118,751
-13,503
| -10% | -$1.69M | 0.03% | 430 |
|
|
2022
Q3 | $14.5M | Buy |
132,254
+14,345
| +12% | +$1.82M | 0.03% | 442 |
|
|
2022
Q2 | $15.6M | Buy |
117,909
+4,899
| +4% | +$643K | 0.03% | 445 |
|
|
2022
Q1 | $15M | Buy |
113,010
+11,906
| +12% | +$1.43M | 0.02% | 512 |
|
|
2021
Q4 | $11.8M | Buy |
101,104
+24,165
| +31% | +$2.84M | 0.02% | 589 |
|
|
2021
Q3 | $9.24M | Buy |
76,939
+10,013
| +15% | +$1.17M | 0.02% | 668 |
|
|
2021
Q2 | $8.02M | Sell |
66,926
-1,311
| -2% | -$144K | 0.01% | 713 |
|
|
2021
Q1 | $6.79M | Sell |
68,237
-8,261
| -11% | -$830K | 0.01% | 730 |
|
|
2020
Q4 | $7.65M | Sell |
76,498
-26,614
| -26% | -$2.82M | 0.01% | 673 |
|
|
2020
Q3 | $11.3M | Sell |
103,112
-20,369
| -16% | -$2.27M | 0.02% | 520 |
|
|
2020
Q2 | $13.1M | Buy |
123,481
+19,673
| +19% | +$2.03M | 0.03% | 466 |
|
|
2020
Q1 | $9.27M | Sell |
103,808
-29,479
| -22% | -$2.78M | 0.02% | 505 |
|
|
2019
Q4 | $13.3M | Buy |
133,287
+97,839
| +276% | +$9.21M | 0.03% | 502 |
|
|
2019
Q3 | $3.16M | Sell |
35,448
-5,798
| -14% | -$503K | 0.05% | 291 |
|
|
2019
Q2 | $3.4M | Sell |
41,246
-8,705
| -17% | -$683K | 0.06% | 271 |
|
|
2019
Q1 | $4.04M | Sell |
49,951
-15,630
| -24% | -$1.23M | 0.07% | 251 |
|
|
2018
Q4 | $4.98M | Sell |
65,581
-12,033
| -16% | -$940K | 0.1% | 203 |
|
|
2018
Q3 | $6.14M | Sell |
77,614
-5,809
| -7% | -$439K | 0.11% | 206 |
|
|
2018
Q2 | $5.86M | Sell |
83,423
-4,689
| -5% | -$337K | 0.11% | 214 |
|
|
2018
Q1 | $6.16M | Buy |
88,112
+6,034
| +7% | +$418K | 0.12% | 213 |
|
|
2017
Q4 | $5.7M | Buy |
82,078
+5,927
| +8% | +$400K | 0.11% | 226 |
|
|
2017
Q3 | $5.16M | Buy |
76,151
+3,875
| +5% | +$245K | 0.1% | 238 |
|
|
2017
Q2 | $4.93M | Buy |
72,276
+3,980
| +6% | +$260K | 0.1% | 247 |
|
|
2017
Q1 | $4.25M | Sell |
68,296
-9,688
| -12% | -$564K | 0.09% | 260 |
|
|
2016
Q4 | $4.26M | Sell |
77,984
-10,811
| -12% | -$614K | 0.09% | 255 |
|
|
2016
Q3 | $5.83M | Buy |
88,795
+7,561
| +9% | +$494K | 0.12% | 207 |
|
|
2016
Q2 | $4.91M | Buy |
81,234
+7,199
| +10% | +$418K | 0.1% | 228 |
|
|
2016
Q1 | $4.17M | Buy |
74,035
+21,035
| +40% | +$1.26M | 0.11% | 213 |
|
|
2015
Q4 | $3.6M | Buy |
53,000
+18,779
| +55% | +$1.23M | 0.09% | 235 |
|
|
2015
Q3 | $2.18M | Buy |
34,221
+18,030
| +111% | +$1.19M | 0.06% | 300 |
|
|
2015
Q2 | $1.03M | Sell |
16,191
-2,897
| -15% | -$198K | 0.03% | 379 |
|
|
2015
Q1 | $1.31M | Sell |
19,088
-5,458
| -22% | -$379K | 0.04% | 344 |
|
|
2014
Q4 | $1.73M | Sell |
24,546
-6,477
| -21% | -$464K | 0.05% | 302 |
|
|
2014
Q3 | $2.22M | Sell |
31,023
-29,236
| -49% | -$2.14M | 0.07% | 263 |
|
|
2014
Q2 | $4.48M | Sell |
60,259
-22,620
| -27% | -$1.64M | 0.13% | 188 |
|
|
2014
Q1 | $5.38M | Sell |
82,879
-3,264
| -4% | -$211K | 0.17% | 149 |
|
|
2013
Q4 | $5.12M | Buy |
86,143
+5,676
| +7% | +$308K | 0.16% | 156 |
|
|
2013
Q3 | $4.18M | Buy |
80,467
+3,324
| +4% | +$167K | 0.15% | 176 |
|
|
2013
Q2 | $3.65M | Buy |
+77,143
| New | +$3.93M | 0.14% | 184 |
|
Other funds holding AZN
IA
VCM
VAM
Truist Financial's AZN Position: Q1 2026 in Review
Truist Financial reduced its AstraZeneca (AZN) stake by 2% in Q1 2026, selling an estimated $2.93M and leaving 754,121 shares worth $149M. The position accounts for 0.2% of the portfolio, ranked #98.
Truist Financial first reported a position in AZN in Q2 2013 and has held it in 52 quarters since. 1,377 funds tracked by Wall St. Rank hold AZN as of Q1 2026.
- Truist Financial held 754,121 shares of AstraZeneca worth $149M as of Q1 2026.
- Truist Financial sold 15,219 AstraZeneca shares in Q1 2026, an estimated $2.93M.
- AstraZeneca made up 0.2% of Truist Financial's portfolio in Q1 2026, its #98 holding.
- Truist Financial first reported a position in AstraZeneca in Q2 2013 and has held it in 52 quarters since.
- 1,377 funds tracked by Wall St. Rank held AstraZeneca as of Q1 2026.
Based on Truist Financial's 13F filing for Q1 2026, filed 27 Apr 2026.